Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theranostic company focused on advancing therapeutic solutions for sepsis and septic shock. The Company develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The Company also offers the Endotoxin Activity Assay (EAA), the diagnostic test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. It provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.


TSX:EDT - Post by User

Post by Revtenon Oct 02, 2025 8:58pm
125 Views
Post# 36736564

TODAY’S NUMBERS

TODAY’S NUMBERS
House Positions for C:EDT from 20251002 to 20251002
House Bought $Val Ave Sold $Val Ave Net $Net
2 RBC 37,300 52,650 1.412 5,738 8,146 1.42 31,562 -44,504
7 TD Sec 51,626 73,004 1.414 25,829 36,208 1.402 25,797 -36,796
80 National Bank 8,265 11,726 1.419 6,763 9,450 1.397 1,502 -2,276
36 Latimer 1,329 1,882 1.416 116 161 1.388 1,213 -1,721
39 Merrill Lynch 7,800 10,849 1.391 6,700 9,428 1.407 1,100 -1,421
79 CIBC 19,746 27,566 1.396 19,346 27,175 1.405 400 -391
88 Credential 0   115 161 1.40 -115 161
124 Questrade 0   855 1,222 1.429 -855 1,222
14 Virtu ITG 220 308 1.40 2,000 2,780 1.39 -1,780 2,472
19 Desjardins 1,414 1,979 1.40 3,500 4,865 1.39 -2,086 2,886
53 Morgan Stanley 0   5,291 7,407 1.40 -5,291 7,407
1 Anonymous 11,100 15,507 1.397 17,300 24,388 1.41 -6,200 8,881
85 Scotia 2,157 3,035 1.407 8,399 11,674 1.39 -6,242 8,639
9 BMO Nesbitt 0   11,805 16,734 1.418 -11,805 16,734
3 ATB 0   27,200 38,709 1.423 -27,200 38,709
TOTAL 140,957 198,506 1.408 140,957 198,508 1.408 0 2

Note The Average Share Price today just under $1.41. A Close at $1.37......??

The Volume is still very insignificant and price can be whatever but Nothing Has Changed. We are just that much closer to FDA SUBMISSION and some additional Data which should be released upon Submission. 

This is an Excellent Buying Opportunity (which I have taken full advantage of) as we will not be at these levels for very long IMHO :)

Kind of SCREAMING BUY TERRITORY actually. 

All The Best!
Rev

<< Previous
Bullboard Posts
Next >>